5 active not recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 5 |
Follow IFL protocol: new trials by email Literature Review of IFL protocol trials Research Report on IFL protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation Onvansertib, FOLFIRI, Bevacizumab - Metastatic Colorectal Cancer, CRC | Phase 2 | Active not recruiting | Cardiff Oncology | 110 | 2024-02-27 | 2026-06-16 |
| A Study of PM8002 in Combination With Chemotherapy in Patients With NEN PM8002, FOLFIRI - Neuroendocrine Neoplasm | Phase 2 | Active not recruiting | Biotheus Inc. | 31 | 2023-05-17 | 2026-07-09 |
| CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen Cetuximab, FOLFIRI, FOLFOX regimen - Metastatic Colorectal Adenocarcinoma | Phase 2 | Active not recruiting | University of Campania Luigi Vanvitelli | 219 | 2021-07-15 | 2025-05-25 |
| OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC FOLFIRI, OSE2101 - Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer | Phase 2 | Active not recruiting | GERCOR - Multidisciplinary Oncology Cooperative Group | 106 | 2021-04-10 | 2025-07-25 |
| Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC Panitumumab, Cetuximab, Irinotecan - Metastatic Colorectal Cancer | Phase 2 | Active not recruiting | University of Wisconsin, Madison | 34 | 2020-10-19 | 2026-06-10 |
Colorectal Neoplasms (2) · Neoplasm Metastasis (1) · Neuroendocrine Tumors (1)
Biotheus Inc. (1) · Cardiff Oncology (1) · GERCOR - Multidisciplinary Oncology Cooperative Group (1) · University of Campania Luigi Vanvitelli (1) · University of Wisconsin, Madison (1)
United States (2) · China (1) · France (1) · Italy (1)
Dustin Deming, MD (1) · Fortunato Ciardiello (1) · Jianming Xu (1)